Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland on track to vaccinate 80% of population by June

Wed, 14th Apr 2021 19:43

(Alliance News) - Ireland remains on track to meet its target of giving four out of five people their first vaccine dose by June, the government has said.

A double setback to the vaccine rollout earlier this week was tempered by news of around 550,000 extra doses of the Pfizer jab to be delivered in quarter two this year.

News of the extra jabs secured by the European Commission came during Wednesday's Cabinet meeting, and was a "welcome relief" to ministers, sources said.

It came after health experts recommended the AstraZeneca PLC vaccine only be given to people over 60 in Ireland, and delays to the Johnson & Johnson/Janssen vaccine over safety concerns.

Taoiseach Micheal Martin told RTE: "The commission's announcement in terms of securing the additional doses puts the programme on track in terms of the key targets."

Sources said the government is still hopeful that 80% of the adult population will be vaccinated by June.

A statement issued after Wednesday's Cabinet meeting said the government is "recalibrating its approach" to the rollout.

"The immediate focus of the vaccine plan is on those at higher risk and those aged 60 and over, and that rollout is continuing. The remainder of the population in order of age will follow," the statement said.

"The government will continue to make every effort to ensure that the vaccine rollout is a successful one so that we can all look forward to the restrictions being lifted over the next while as we look forward to the summer."

There was no mention of the target to vaccinate all adults by September.

Health Minister Stephen Donnelly told Newstalk: "It's been a bumpy week, a very busy week. But ultimately where we're at right now is, we're still on target.

"The programme will be changing and reprofiling. We've done this before and we will do it again before this is all over.

"But we're working hard to make sure we do the best that we can do, which is get the vaccines out as they come into the country."

One possibility to speed up the rollout discussed at Cabinet was longer intervals between vaccine doses, with studies showing a high level of immunity after a single dose.

It is understood the issue is under review and no decision has been made.

Donnelly said: "What we're finding is that these vaccines are so effective that people are getting north of 80% protection from the first dose. So really the focus for the end of June is the first dose."

The government is hopeful that the Johnson & Johnson vaccine will still be given approval by the European Medicines Agency at a meeting next Tuesday.

On Tuesday, J&J delayed distribution of its vaccine to Europe after US regulators recommended a pause to give time to investigate reports of a rare blood-clotting side effect.

The move was made out of an "abundance of caution", the US Food and Drugs Administration and the Centres for Disease Control & Prevention said in a joint statement.

Tanaiste Leo Varadkar said Ireland's share of roughly 550,000 doses from the EU will help to make up the shortfall caused by uncertainties over the J&J vaccine.

Ireland had been due to receive 600,000 doses of the single-shot jab by the end of June.

Varadkar tweeted on Wednesday: "What we lost yesterday in terms of Q2 vaccine supply from Janssen we regained today with an extra 550k Pfizer shots.

"Janssen may yet get the green light. Vaccine programme still broadly on track."

At a press conference on Wednesday, European Commission president Ursula von der Leyen said: "As we can see with the announcement by Johnson & Johnson yesterday, there are still many factors that can disrupt the planned delivery schedule of vaccines.

"It is therefore important to act swiftly, anticipate and adjust whenever possible.

"We are doing everything in our power to support Europe's vaccination rollout, also by increasing the supply of vaccines in the coming weeks and months.

"This is why I am pleased to announce that we have reached an agreement with BioNTech SE-Pfizer Inc to, once again, speed up the delivery of vaccines.

"Fifty million additional doses of BioNTech-Pfizer vaccines will be delivered in quarter two of this year, starting in April.

"Those 50 million doses were initially foreseen for delivery in the fourth quarter of 2021. Now, they are available in quarter two."

Ireland's vaccine rollout was dealt two significant blows this week.

On Monday, health authorities in Ireland limited the use of the AstraZeneca jab to people over 60, prompted by concerns around rare blood clots.

On Tuesday, J&J delayed distribution of its vaccine to Europe after the US pause.

On Wednesday, Liz Canavan, assistant secretary general at the Department of the Taoiseach, warned that Ireland's low level of vaccination meant the country could face another wave of the virus.

She said: "While significant progress is being made in controlling the disease and in rolling out vaccines, we still have a high level of infections.

"We are dealing with a much more transmissible virus than last year. The absolute number of people fully protected through vaccination remains low.

"This means the risk of Covid is still with us and that Ireland could experience a further wave of infections if public health restrictions are eased too quickly or we don't stick to the plan.

"The priority must remain in the coming weeks on controlling this disease.

"These few weeks are crucial. So far the careful approach is working. We are still on track which means brighter days and further easing of restrictions won't be too far away. We will get there."

To date Ireland has administered 1,076,216 vaccines – 758,763 first doses and 317,453 second doses.

There were 12 additional deaths related to Covid-19 and another 431 confirmed cases reported on Wednesday, the Department of Health said.

Four of the deaths occurred in April, two in March and six in January.

On Wednesday morning, there were 192 Covid-19 patients in hospital, with 49 in intensive care.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.